An announcement from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited, a company in the healthcare and pharmaceutical industry, announced its financial results for the six months ending December 31, 2024. The company reported a 9% decrease in revenue from continuing operations, totaling AUD $5,991,410. Despite this decline, EBOS Group continues to focus on enhancing shareholder value, as indicated by a final dividend declaration of NZD $0.57 per share. The net profit from continuing operations also saw a decrease of 18.9%, amounting to AUD $110,489. This financial performance reflects the company’s ongoing challenges, including restructuring and acquisition-related costs.
More about EBOS Group Limited
YTD Price Performance: 11.44%
Average Trading Volume: 30,142
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$7.28B
See more insights into EBO stock on TipRanks’ Stock Analysis page.